baclofen has been researched along with ziconotide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gerayli, A; Ridgeway, B; Wallace, M | 1 |
Taira, T | 1 |
Burton, AW; Danyo, DA; Frost, S; Glanzer, J; Saulino, M; Solanki, DR | 1 |
Deer, T; Rauck, RL; Wallace, MS | 1 |
Asensio-Samper, JM; De Andres, J; Fabregat-Cid, G | 1 |
Calabrese, C; Estraneo, A; Lanzillo, B; Loreto, V; Moretta, P; Trojano, L | 1 |
Goldstein, RB; Kohan, LR; Zhu, X | 1 |
Asensio-Samper, JM; De Andrés, J; De Andres-Serrano, C; Fabregat-Cid, G; Rubio-Haro, R | 1 |
4 review(s) available for baclofen and ziconotide
Article | Year |
---|---|
[Chronic intrathecal drug administration for the control of intractable pain].
Topics: Amines; Analgesics, Opioid; Anesthetics, Local; Baclofen; Calcium Channel Blockers; Clonidine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Infusion Pumps, Implantable; Injections, Spinal; Morphine; Neoplasms; Neuralgia; omega-Conotoxins; Pain, Intractable | 2008 |
Ziconotide combination intrathecal therapy: rationale and evidence.
Topics: Analgesics; Baclofen; Clonidine; Drug Therapy, Combination; Humans; Injections, Spinal; Morphine; omega-Conotoxins; Pain; Treatment Outcome | 2010 |
Intrathecal delivery of analgesics.
Topics: Analgesics, Opioid; Baclofen; Bupivacaine; Catheters, Indwelling; Chronic Pain; Clonidine; Drug Delivery Systems; Humans; Inflammation; Infusion Pumps, Implantable; Injections, Spinal; Neoplasms; omega-Conotoxins; Psychiatric Status Rating Scales; Spine | 2014 |
Intrathecal Drug Delivery.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Baclofen; Cancer Pain; Chronic Pain; Drug Delivery Systems; GABA-B Receptor Agonists; Humans; Infusion Pumps, Implantable; Muscle Relaxants, Central; Muscle Spasticity; Neuroprotective Agents; omega-Conotoxins; Pain Management; Risk Factors | 2020 |
4 other study(ies) available for baclofen and ziconotide
Article | Year |
---|---|
Ziconotide for the treatment of severe spasticity after spinal cord injury.
Topics: Adult; Analgesics, Opioid; Baclofen; Calcium Channel Blockers; Drug Resistance; Humans; Male; Morphine; Muscle Relaxants, Central; Muscle Spasticity; omega-Conotoxins; Paraplegia; Quadriplegia; Spinal Cord Injuries | 2000 |
Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
Topics: Adult; Baclofen; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity; Neuralgia; Neuroprotective Agents; omega-Conotoxins; Pain; Pain Measurement; Treatment Outcome | 2009 |
Does pain relief influence recovery of consciousness? A case report of a patient treated with ziconotide.
Topics: Adult; Analgesics, Non-Narcotic; Baclofen; Brain Injuries, Traumatic; Humans; Male; Muscle Relaxants, Central; omega-Conotoxins; Persistent Vegetative State | 2016 |
Low-Dose Intrathecal Ziconotide for Spasticity From Primary Lateral Sclerosis: A Case Report.
Topics: Adult; Baclofen; Female; Humans; Injections, Spinal; Motor Neuron Disease; Muscle Spasticity; omega-Conotoxins; Pain; Treatment Outcome | 2019 |